Analyst Ratings for Mednax Inc. (MD)

Updated: 2017-07-26

Shares of Mednax Inc. (NYSE:MD) have received a consensus rating of Hold from Wall Street analysts. A consensus rating of Hold was previously issued for MD last month.

Of the 14 analysts covering the stock, 2 gave it a buy rating, 0 gave an overweight rating, 11 issued a hold rating, 1 gave an underweight rating, and 0 issued a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has increased by 0. Meanwhile, the number of analysts pessimistic about the company has increased by 0.

MD was given price targets by several analysts. The most optimistic analyst gave a price target of 68, which equates to a potential upside of 20.06 percent. The most pessimistic analyst gave a price target of 53, implying potential capital losses of -6.43 percent. Note that investment analysts can be biased in their reporting on companies's ratings and price targets.

In the last 30 days, analysts have changed their quarterly earnings estimates upwards by an average of 0 percent. The average change in earnings estimates over the last 90 days is -16.86 percent. On the other hand, earnings estimates for the fiscal year have been revised downwards by -0.72 percent, as compared to a month ago. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes -13.41 percent.

Another thing investors often look at is the level of agreement among analysts' revisions. 0 analysts have revised their quarterly estimates upwards in the past 30 days, which can be compared to the 0 analysts that decreased their estimates. During this time, 0 analysts made positive revisions in their estimates for this fiscal year's earnings, compared to 2 analysts that revised their FY estimates downwards.

Analysts estimate earnings of MD to grow at a rate of -1.81 percent. Another measure frequently examined by investors is the PEG ratio. Investors like to see smaller values for the PEG ratio, as that can indicate whether the high price level of a stock is warranted by high growth. People often look for the PEG ratio to be under 1, but many choose to perform ratio comparisons with other companies in the industry. The PEG ratio of MD is -9.31.

MD has traded between a high of 75.83 and a low of 53.80 over the past year. The current market price is above the trailing year's low by 5.28 percent, and below the high by 25.31 percent. MD has a P/E ratio of 16.86. Investors typically compare the P/E ratio to a company's peers in the industry. The MD value stock report compares MD to some of its peers using value stock charts. The market cap of MD is $5.33 billion. MD will post this quarters earnings in days, on 0000-00-00.